Large-scale real-world data continue to expand our understanding of arrhythmia detection. New findings published in Heart Rhythm show that, among more than one million patients monitored with iRhythm’s Zio LTCM service, short-term (24–48-hour) monitoring can miss actionable arrhythmias, even in patients reporting daily symptoms, and that symptom–rhythm correlation is low across most arrhythmias.[1] At AHA 2025, data from more than 742,000 Zio LTCM monitoring devices showed that patients who self-apply and activate the device at home achieve high compliance, strong engagement, and data quality comparable to in-clinic application.[2] Additional CKM and CKD analyses revealed earlier arrhythmia risk emerging across the CKM syndrome continuum.[3-5] Taken together, these findings reinforce why iRhythm is committed to expanding access to long-term continuous monitoring—supporting earlier rhythm assessment for the estimated 27 million people in the U.S. who may be at risk for undiagnosed arrhythmias, and many more worldwide. See more here: https://lnkd.in/g7hgtEYe #iRhythmTechnologies #Zio #Arrhythmia #AHA2025 #RWE
iRhythm's Zio LTCM service: expanding arrhythmia detection
This title was summarized by AI from the post below.
More Relevant Posts
-
🫀 Did you know that more than 1.2 million people in the UK live with a heart rhythm disorder, known as an arrhythmia, such as atrial fibrillation and atrial flutter? In this post, Dr Oliver Segal, Consultant Cardiologist and Electrophysiologist at The Harley Street Clinic, answers some of the most common questions about arrhythmias, from causes and symptoms to diagnosis and treatment. At HCA Healthcare UK, we’re proud to offer treatment using the Affera system - a ground-breaking catheter ablation technology that represents the most advanced and effective solution available for treating complex heart rhythm disorders. 🔗 Learn more about arrhythmias and the treatments we offer: https://lnkd.in/ePNgF7-v #HCAHealthcareUK #HCAUK #HeartArrhythmias #Arrhythmias #CardiacHealth #CardiacCare
-
This post hoc analysis of the STRENGTH trial in statin-treated patients at high cardiovascular risk indicated that, compared with corn oil, treatment with ω-3 CA was associated with a lower incidence of the primary endpoint (5-point composite MACE) in Asian patients but not in non-Asian patients. Given the limitations inherent to post hoc analyses, the fact that the Asian cohort represented about 10% of the total sample, and the early termination of STRENGTH, these findings should be viewed as hypothesis-generating for further study. Learn more about the results of this study on our website. ➡️ https://lnkd.in/eH_N_JkH #R3i #ResidualRisk #ResidualRiskReduction #MedicalResearch #Cardiovascular #CardiovascularHealth #CardiovascularDisease #CVD #STRENGTH #STRENGTHtrials
-
-
Early CKD detection = better outcomes. 🩺 Learn to spot risks using proven screening tools ❤️ Understand CKD’s cardiovascular impact 🚀 Apply evidence-based strategies to improve patient care. 👉 http://ms.spr.ly/6046sC6dw
-
-
When evaluating precordial leads, the presence of tall, sharp, pointed T waves can be indicative of hyperkalemia. As hyperkalemia progresses, these T waves may evolve into wide QRS complexes and eventually a sine wave pattern, often associated with cardiac arrest. In patients with chest pain and a left bundle branch block, it's crucial to assess for MI patterns using Sgarbossa criteria. Discordance, where ST elevation opposes the QRS complex, is normal, while concordance, where both rise together, is abnormal and concerning. It’s essential to recognize these ECG changes promptly to guide appropriate interventions and potentially prevent adverse outcomes. #cardiacarrest #ECGinterpretation #hyperkalemia #Sgarbossacriteria #leftbundlebranchblock
-
Happy to share our latest publication in JCM! 🫀 “Uncommon and Accessory Electrocardiographic Findings in Brugada Syndrome” explores atypical ECG patterns that may challenge diagnosis of BrS https://lnkd.in/dYHhkD7Z
-
Catheter ablation for atrial fibrillation might be missing half its potential, after results from the ARREST-AF trial demonstrated that structured lifestyle and risk factor management significantly increases a patient’s 12-month freedom from arrhythmia while cutting recurrence risk nearly in half. https://lnkd.in/eRHbSxFc
-
Catheter ablation for atrial fibrillation might be missing half its potential, after results from the ARREST-AF trial demonstrated that structured lifestyle and risk factor management significantly increases a patient’s 12-month freedom from arrhythmia while cutting recurrence risk nearly in half. https://lnkd.in/eRHbSxFc
-
Dr Mintu Turakhia MD MS highlights how 14-day monitoring captures more arrhythmias beyond the first week, with patient-centered convenience👉 https://ow.ly/8GRI50Xq27c 📊 In the AMALFI study, despite a mean age of almost 80 and comorbidities like heart failure, stroke, and CKD, patients achieved a median wear time of 13.9 days, showing strong tolerability and compliance. Sponsored by iRhythm Technologies International.
-
Case of the Day 126: Unexplained PH Decoded 65-yrs old with PH and RV dysfunction for evaluation. Initially considered for edge-to-edge tricuspid repair. In patients with PH, radiologists can make a difference in identifying a few pathologies as causes of PH (leaving aside known cardiac and pulmonary diseases, where the conditions are already known). We should not miss these, especially shunts. Video https://lnkd.in/d5ECrhfC #cmrsimplified #cmr #cardiacmri #whyCMR #PH #pulmonaryhypertension #shunt
-
-
||ACUTE MEDICINE||ANTIMICROBIAL STEWARDSHIP|| ||CFAID|| AMR-IPC|| ||CERTIFIED BLS, ACLS, PALS PROVIDER|| Certified in Emergency Medicine Core Content Course|| Certified in Emergency obstetrics and Newborn care||
Day 33: Vasopressin in Septic Shock — What We Often Miss. When added to norepinephrine, vasopressin isn’t just a dose-sparing adjunct. It’s a fixed-dose agent that replenishes depleted vasopressin levels, stabilizes MAP without worsening tachyarrhythmias, and avoids the pulmonary hypertension burden of catecholamines. But beware: overshooting MAP can risk digital and mesenteric ischemia. High infusion doses? A cardiac arrest trigger. 🔍 Clinical nuance saves lives. 100DaysOfClinicalNuance #SepsisManagement #CriticalCarePharmacology #MedicalEducation #DrJyothiJetti #ClinicalNuance #ICUInsights #PharmacologyPearls #LinkedInMedEd
-
